GRAIL, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position
GRAIL, Inc. (GRAL) had Debt Securities, Available-for-sale, Unrealized Loss Position of $806.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $806.00M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $404.60M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $18.30M.
- 2025-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $291.70M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $806.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $404.60M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $18.30M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $291.70M 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |